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Arthropod vectors such as mosquitoes, ticks and sand flies transmit diseases 
that greatly impact human and animal health. Emerging and re-emerging 
vector-borne diseases (VBDs), some of which affect large populations in 
tropical and subtropical countries, include malaria, dengue, Yellow fever, louse-
borne typhus, plague, leishmaniasis, sleeping sickness, West Nile encephalitis, 
Lyme disease, Japanese encephalitis, Rift Valley fever, anaplasmosis, 
babesiosis and Crimean-Congo hemorrhagic fever (Gubler, 1998 and Jones et 
al., 2008). However, despite the impact of VBDs on human and animal health, 
few VBDs such as Yellow fever have effective vaccines. The factors affecting 
the occurrence of VBDs include (a) the abundance of vectors and reservoir 
hosts, (b) the prevalence of pathogens adapted to vectors and vertebrate hosts, 
(c) the local environmental conditions, and (d) the behavior and immune status 
of the human and animal populations at risk. Thus, the control of arthropod 
vectors is important for the eradication of VBDs (de la Fuente et al., 1998, de la 
Fuente et al., 2007, de la Fuente et al., 2011 and Merino et al., 2011). The 
review paper by Luís Parizi and Naftaly Githaka and their colleagues, published 
in this issue of The Veterinary Journal, clearly covers the need and potential to 
develop universal vaccines for the control of multiple tick species infestations 
( Parizi et al., 2012). Vaccination is an environmentally friendly alternative for 
vector control that allows control of several VBDs by targeting their common 
vector (de la Fuente et al., 1998, de la Fuente et al., 2007, de la Fuente et al., 
2011 and Merino et al., 2011). Almost 30 years ago, Elvin and Kemp 
(1994) proposed that a candidate tick protective antigen should fulfil certain 
important criteria, namely, (1) host antibodies should be able to gain access to 
the target protein in sufficient quantities; (2) the formation of the antibody–
antigen complex should disrupt the function of the target protein and/or induce 
physiological changes that affect vector biology, and (3) the antigen should 
share conserved epitopes among several tick species to protect against multiple 
vector infestations. These criteria are still valid for the discovery of vector 
protective antigens, perhaps with the added rider that the vaccine should also 
reduce vector populations and vector capacity for VBDs. In their review, Parizi 
et al. (2012) address these criteria for tick protective antigens with special 
emphasis on the need to produce cross-reactive antibodies in immunized hosts 
to control multiple tick species infestations – a factor critical for tick control in 
many regions of the world. The experience with BM86-based vaccines, the only 
commercial vaccines that have been developed against arthropods, supports 
the possibility of controlling multiple tick species and suggests that reduction of 
tick populations has an impact on the prevalence of some tick-borne pathogens 
(de la Fuente et al., 1998 and de la Fuente et al., 2007). Despite the limitations 
of BM86-based vaccines for the control of some tick species and the fact that 
these vaccines do not affect tick vector capacity, the development of tick 
vaccines based on BM86 orthologs is still a viable and valid option for tick 
control as part of integrated control strategies aimed at reducing tick 
populations and the use of chemical acaricides that have resulted in the 
selection of acaricide-resistant ticks in some regions. However, as Parizi et al. 
(2012) point out, novel antigens are required to develop the next generation of 
vaccines for a more effective control of multiple tick species.  
Ultimately, these antigens should also allow control of other arthropod vectors 
and the transmission of vector-borne pathogens. Recent developments using 
subolesin and akirin, ortholog proteins in ticks and insects that affect the 
expression of signal transduction and innate immune response genes (Goto et 
al., 2008, Galindo et al., 2009 and de la Fuente et al., 2011) have provided 
evidence of the possibilities for controlling multiple vector species (hard and soft 
ticks, mosquitoes, sand flies, poultry red mites and sea lice) and the infection by 
tick-borne pathogens (Anaplasma phagocytophilum, A. marginale and Babesia 
bigemina) using conserved antigens ( de la Fuente et al., 2007, Moreno-Cid et 
al., 2011 and Merino et al., 2011). Experiments with subolesin/akirin also 
showed that it might be possible to use intracellular antigens to develop 
vaccines for the control of vector infestations (de la Fuente et al., 2011). The 
exact mechanisms by which anti-subolesin/akirin antibodies affect vector 
infestation and fertility are unknown, but may include interference with protein 
biological function and/or interaction with conserved epitopes in other proteins 
essential for the parasite (de la Fuente et al., 2011). Systems biology 
approaches to research on vectors and vector-borne pathogens and on the 
vector–host–pathogen interface are generating data allowing the identification 
of key molecules and pathways involved in vector infestations and pathogen 
infection and transmission. However, this huge amount of information requires 
novel algorithms to be developed so that these data can be used to advance 
knowledge on basic biological questions and to develop improved vaccines for 
the control of vector infestations and VBDs. So, the control of VBDs could be 
achieved using vaccines containing arthropod vector antigens alone or in 
combination with pathogen-derived antigens to control both arthropod 
populations and the infection and transmission of vector-borne pathogens. An 
important advantage of arthropod vaccines will most likely be the ability to 
reduce or prevent transmission of several pathogens through immunization of 
reservoir hosts and human and animal populations at risk. The review by Parizi 
et al. (2012) convincingly emphasizes the need to produce vaccines to target 
multiple vector species in vaccinated hosts. These vaccines could be obtained 
using highly immunogenic antigens conserved across multiple vector species 
and targeting functionally relevant proteins and pathways for both vector 
infestations and pathogen infection and transmission. The efficacy of antigen 
combinations and chimeras containing protective epitopes from different 
antigens is difficult to predict and require empirical evaluations, but should be 
considered for the development of next generation vaccines for the control of 
VBDs. The development of vaccines for vector control is still in its infancy but 
the results obtained in the last 20 years have demonstrated the possibilities and 
advantages of this approach to control vector infestations and pathogen 
infection and encourage support to expand research in this area to contribute to 
the eradication of VBDs. 
 
